← All indications
Diffuse Intrinsic Pontine Glioma
A rare, aggressive brain tumor that forms in the GLIAL CELLS in the PONS.
Drugs by status
Phase 3 trials (5)
Phase 2 trials (42)
- antineoplaston AS2-1
- atengenal
- irinotecan
- cbl0137
- eflornithine
- selinexor
- doxorubicin
- dsp-7888
- olutasidenib
- gdc-0084
- vismodegib
- indoximod
- ribociclib
- pidilizumab
- mebendazole
- nimotuzumab
- vincristine
- panobinostat
- pep-cmv
- carboplatin
- cyclophosphamide
- bevacizumab
- cetuximab
- dasatinib
- tsr-022
- dostarlimab
- vinorelbine
- vorinostat
- Tetanus and diphtheria toxoids adsorbed
- antigen pulsed dendritic cells
- +12 more
Phase 1 trials (53)
- abemaciclib
- ad-rts-hil-12
- agen1884
- apx005m
- atovaquone
- mk-1775
- bxq-350
- lenalidomide
- temsirolimus
- cilengitide
- Iopofosine
- crenolanib
- cudc-907
- gemcitabine
- imiquimod
- incb7839
- pembrolizumab
- larotrectinib
- lorlatinib
- marizomib
- motexafin gadolinium
- palbociclib
- ptc596
- autologous dendritic cells
- ttrna-dcs
- ttrna-xalt
- veledimex
- veliparib
- wild-type reovirus
- crizotinib
- +23 more